dantrolene has been researched along with Rhabdomyolysis in 48 studies
Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.
Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dantrolene sodium (Dantrium) has been used extensively for the treatment of myopathies in man and anecdotal evidence suggests it is of clinical benefit in the control of exercise-induced rhabdomyolysis (ER) in racehorses, although data to support this are currently lacking." | 9.10 | The efficacy of dantrolene sodium in controlling exertional rhabdomyolysis in the Thoroughbred racehorse. ( Edwards, JG; Newtont, JR; Pilsworth, RC; Ramzan, PH; Shepherd, MC, 2003) |
| "To determine the effect of oral administration of dantrolene sodium on serum creatine kinase (CK) activity after exercise in horses with recurrent exertional rhabdomyolysis (RER)." | 7.72 | Effect of oral administration of dantrolene sodium on serum creatine kinase activity after exercise in horses with recurrent exertional rhabdomyolysis. ( Finno, CJ; Godden, SM; McKenzie, EC; Murphy, MJ; Valberg, SJ, 2004) |
| "A 29-year-old man with C6 tetraplegia (ASIA A) using an implanted baclofen pump and intrathecal catheter infusion system for spasticity control developed severe spasticity, hyperthermia, hypotension, rhabdomyolysis, and disseminated intravascular coagulation after catheter disconnection." | 7.70 | Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure. ( Christopherson, MW; Reeves, RK; Stolp-Smith, KA, 1998) |
| "A patient with recurrent attacks of exertional rhabdomyolysis and easy fatiguability was treated with dantrolene sodium." | 7.67 | Prevention of recurrent exertional rhabdomyolysis by dantrolene sodium. ( Haverkort-Poels, PJ; Joosten, EM; Ruitenbeek, W, 1987) |
| "Dantrolene has shown promising results in controlling muscle symptoms in individuals with ERM, however, its use in children remains poorly documented." | 5.91 | Oral Dantrolene Reduces Myalgia and Hyperckemia in a Child with RYR1-Related Exertional Myalgia/Rhabdomyolysis. ( Aschoff, CAM; de Lima Silva, EV; de Souza, CFM; Donis, KC; Machado, FRC; Poswar, FO; Saute, JAM; Simão Medeiros, L, 2023) |
| "Dantrolene is a ryanodine receptor antagonist and is used as an anti-inflammatory agent." | 5.62 | Beneficial effects of dantrolene in the treatment of rhabdomyolysis as a potential late complication associated with COVID-19: a case report. ( Chiba, N; Kinoshita, K; Matsuzaki, M; Mawatari, T; Mizuochi, M; Sakurai, A, 2021) |
| "Dystonia is of particular concern as a dystonic storm can ensue leading to rhabdomyolysis." | 5.56 | Recurrent Dystonic Crisis and Rhabdomyolysis Treated with Dantrolene in Two Patients with Aromatic L-Amino Acid Decarboxylase Deficiency. ( Horvath, G; Micallef, J; Salvarinova-Zivkovic, R; Stockler-Ipsiroglu, S; van Karnebeek, CD, 2020) |
| "Dantrolene sodium (Dantrium) has been used extensively for the treatment of myopathies in man and anecdotal evidence suggests it is of clinical benefit in the control of exercise-induced rhabdomyolysis (ER) in racehorses, although data to support this are currently lacking." | 5.10 | The efficacy of dantrolene sodium in controlling exertional rhabdomyolysis in the Thoroughbred racehorse. ( Edwards, JG; Newtont, JR; Pilsworth, RC; Ramzan, PH; Shepherd, MC, 2003) |
| " They include: (1) How much dantrolene should be available in facilities where volatile agents are not available or administered, and succinylcholine is only stocked on site for emergency purposes? (2) What defines masseter muscle rigidity? What is its relationship to MH, and how should it be managed when it occurs? (3) What is the relationship between MH susceptibility and heat- or exercise-related rhabdomyolysis? (4) What evidence-based interventions should be recommended to alleviate hyperthermia associated with MH? (5) After treatment of acute MH, how much dantrolene should be administered and for how long? What criteria should be used to determine stopping treatment with dantrolene? (6) Can patients with a suspected personal or family history of MH be safely anesthetized before diagnostic testing? This report describes the consensus process and the outcomes for each of the foregoing unanswered clinical questions." | 3.91 | Consensus Statement of the Malignant Hyperthermia Association of the United States on Unresolved Clinical Questions Concerning the Management of Patients With Malignant Hyperthermia. ( Larach, MG; Litman, RS; Mayes, L; Shukry, M; Smith, VI; Theroux, MC; Watt, S; Wong, CA, 2019) |
| " Following initial improvement, she developed delayed rhabdomyolysis then haloperidol-induced neuroleptic malignant syndrome, which was treated with a total of 50 mg." | 3.78 | Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene. ( Hawryluck, LA; Kraeva, N; Riazi, S; Russell, T; Steel, AC, 2012) |
| " Exposure of CASQ1-null mice to either 2% halothane or heat stress triggers lethal episodes characterized by whole-body contractures, elevated core temperature, and severe rhabdomyolysis, which are prevented by prior dantrolene administration." | 3.75 | Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice. ( Canato, M; Dainese, M; Dirksen, RT; Lyfenko, AD; Paolini, C; Protasi, F; Quarta, M; Reggiani, C, 2009) |
| " We present a detailed description of the case and also discuss the role of propofol and rhabdomyolysis." | 3.72 | A fatal case of malignant hyperthermia complicated by generalized compartment syndrome and rhabdomyolysis. ( Green, G, 2003) |
| "To determine the effect of oral administration of dantrolene sodium on serum creatine kinase (CK) activity after exercise in horses with recurrent exertional rhabdomyolysis (RER)." | 3.72 | Effect of oral administration of dantrolene sodium on serum creatine kinase activity after exercise in horses with recurrent exertional rhabdomyolysis. ( Finno, CJ; Godden, SM; McKenzie, EC; Murphy, MJ; Valberg, SJ, 2004) |
| "A 29-year-old man with C6 tetraplegia (ASIA A) using an implanted baclofen pump and intrathecal catheter infusion system for spasticity control developed severe spasticity, hyperthermia, hypotension, rhabdomyolysis, and disseminated intravascular coagulation after catheter disconnection." | 3.70 | Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure. ( Christopherson, MW; Reeves, RK; Stolp-Smith, KA, 1998) |
| " Eight days later, he presented with a neuroleptic malignant syndrome following an injection of droperidol." | 3.70 | Malignant hyperthermia and neuroleptic malignant syndrome in a patient during treatment for acute asthma. ( Cardinaud, JP; Favier, JC; Gbikpi-Benissan, G; Gruson, D; Hilbert, G; Portel, L, 1999) |
| "To present a case of rhabdomyolysis which developed in a child with a known history of Duchenne's muscular dystrophy, following an anesthetic which included sevoflurane." | 3.70 | Rhabdomyolysis in association with Duchenne's muscular dystrophy. ( Nakajima, Y; Obata, R; Sato, S; Suzuki, A; Yasumi, Y, 1999) |
| " We report a case of this rare syndrome in a head injury patient associated with some unusual features: rhabdomyolysis with a high level of creatine kinase, the development of acute renal failure, the early use of continuous venovenous haemofiltration in treatment and rigidity that was refractory to conventional treatment with dantrolene and bromocriptine." | 3.69 | Neuroleptic malignant syndrome in a patient with head injury. ( Alted Lopez, E; Ambros Checa, A; Caballero Cubedo, R; Perez-Vela, JL; Sanchez Casado, M; Sanchez-Izquierdo Riera, JA, 1996) |
| "Binge drinking of alcohol, cocaine overdose, or overexertion can lead to rhabdomyolysis characterized by elevated creatine kinase (CK) and myoglobin in the serum, myoglobinuria, and muscle tenderness." | 3.69 | Dantrolene sodium reduces the enhanced leakage of creatine kinase caused by ethanol, cocaine, and electrical stimulation in isolated fast and slow muscles of rat. ( Amaladevi, B; Bernstein, A; Grob, D; Herzlich, B; Namba, T; Pagala, M, 1997) |
| "Neuroleptic malignant syndrome is a rare but serious adverse effect of antipsychotic medication." | 2.37 | Neuroleptic malignant syndrome. ( Levenson, JL, 1985) |
| " Our aim was to investigate the occurrence of serious adverse effects and the adherence to oral dantrolene therapy." | 1.91 | Oral Dantrolene for Myopathic Symptoms in Malignant Hyperthermia-Susceptible Patients: A 25-Year Retrospective Cohort Study of Adverse Effects and Tolerability. ( Ibarra Moreno, CA; Jungbluth, H; Kraeva, N; Riazi, S; Voermans, NC; Zvaritch, E, 2023) |
| "Dantrolene has shown promising results in controlling muscle symptoms in individuals with ERM, however, its use in children remains poorly documented." | 1.91 | Oral Dantrolene Reduces Myalgia and Hyperckemia in a Child with RYR1-Related Exertional Myalgia/Rhabdomyolysis. ( Aschoff, CAM; de Lima Silva, EV; de Souza, CFM; Donis, KC; Machado, FRC; Poswar, FO; Saute, JAM; Simão Medeiros, L, 2023) |
| "Dantrolene is a ryanodine receptor antagonist and is used as an anti-inflammatory agent." | 1.62 | Beneficial effects of dantrolene in the treatment of rhabdomyolysis as a potential late complication associated with COVID-19: a case report. ( Chiba, N; Kinoshita, K; Matsuzaki, M; Mawatari, T; Mizuochi, M; Sakurai, A, 2021) |
| "Dystonia is of particular concern as a dystonic storm can ensue leading to rhabdomyolysis." | 1.56 | Recurrent Dystonic Crisis and Rhabdomyolysis Treated with Dantrolene in Two Patients with Aromatic L-Amino Acid Decarboxylase Deficiency. ( Horvath, G; Micallef, J; Salvarinova-Zivkovic, R; Stockler-Ipsiroglu, S; van Karnebeek, CD, 2020) |
| "The diagnosis of malignant hyperthermia (MH) susceptibility could be confirmed in the patient 4 months after the acute event by the in vitro contracture test and detection of the MH causative mutation p." | 1.48 | [Abortive course of malignant hyperthermia following preclinical induction of general anesthesia using succinylcholine]. ( Helf, D; Johannsen, S; Markus, CK; Schneiderbanger, D; Schuster, F, 2018) |
| "The cardiac arrhythmia was associated with hyperkalemia, metabolic acidosis, and myoglobulinemia." | 1.35 | Rhabdomyolysis after liver transplantation: a case report. ( Chen, CL; Chen, KH; Cheng, KW; Cheng, YF; Chiu, KW; Concejero, AM; Huang, CJ; Huang, TL; Jawan, B; Lin, CC; Liu, YW; Wang, CC; Wang, CS; Wang, SH, 2008) |
| "We report two cases of malignant hyperthermia-like syndrome associated with HHNS in adolescents." | 1.33 | Approach to management of malignant hyperthermia-like syndrome in pediatric diabetes mellitus. ( Backeljauw, PF; Crimmins, NA; Kilbane, BJ; Mehta, S; Shanley, TP, 2006) |
| "With regards to the neuroleptic malignant syndrome dantrolenum and bromocriptin treatment were applied with the discontinuation of neuroleptic medication." | 1.29 | [Acute renal failure in neuroleptic malignant syndrome]. ( Rónai, L; Wagner, G, 1995) |
| "Exertional rhabdomyolysis is a myopathy of unknown pathophysiology." | 1.29 | Elevated myoplasmic calcium in exercise-induced equine rhabdomyolysis. ( Cordovez, G; Linares, N; López, JR; Terzic, A, 1995) |
| "Rhabdomyolysis is a clinical disorder arising from skeletal muscle injury." | 1.29 | The neuroleptic malignant syndrome and acute renal failure. ( Becker, BN; Ismail, N, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (10.42) | 18.7374 |
| 1990's | 17 (35.42) | 18.2507 |
| 2000's | 11 (22.92) | 29.6817 |
| 2010's | 8 (16.67) | 24.3611 |
| 2020's | 7 (14.58) | 2.80 |
| Authors | Studies |
|---|---|
| Ibarra Moreno, CA | 1 |
| Kraeva, N | 2 |
| Zvaritch, E | 1 |
| Jungbluth, H | 1 |
| Voermans, NC | 2 |
| Riazi, S | 2 |
| de Lima Silva, EV | 1 |
| Donis, KC | 1 |
| Machado, FRC | 1 |
| Simão Medeiros, L | 1 |
| Aschoff, CAM | 1 |
| de Souza, CFM | 1 |
| Poswar, FO | 1 |
| Saute, JAM | 1 |
| Micallef, J | 1 |
| Stockler-Ipsiroglu, S | 1 |
| van Karnebeek, CD | 1 |
| Salvarinova-Zivkovic, R | 1 |
| Horvath, G | 1 |
| Kajani, R | 1 |
| Apramian, A | 1 |
| Vega, A | 1 |
| Ubhayakar, N | 1 |
| Xu, P | 1 |
| Liu, A | 1 |
| Nakashima, K | 1 |
| Matsunaga, Y | 1 |
| Ohara, K | 1 |
| Nie, M | 1 |
| Chiba, N | 1 |
| Matsuzaki, M | 1 |
| Mawatari, T | 1 |
| Mizuochi, M | 1 |
| Sakurai, A | 1 |
| Kinoshita, K | 1 |
| Aldrich, K | 1 |
| Velez-Irizarry, D | 1 |
| Fenger, C | 1 |
| Schott, M | 1 |
| Valberg, SJ | 2 |
| Wystub, N | 1 |
| Heymel, S | 1 |
| Fritzenwanger, M | 1 |
| Schulze, PC | 1 |
| Pfeifer, R | 1 |
| Helf, D | 1 |
| Schneiderbanger, D | 1 |
| Markus, CK | 1 |
| Johannsen, S | 1 |
| Schuster, F | 1 |
| Nelson, EP | 1 |
| Dorlon, ME | 1 |
| Szabo, TA | 1 |
| Trollinger, JB | 1 |
| Johnson-Mann, C | 1 |
| Broderick, G | 1 |
| Warters, RD | 1 |
| Ashley, AL | 1 |
| Litman, RS | 1 |
| Smith, VI | 1 |
| Larach, MG | 1 |
| Mayes, L | 1 |
| Shukry, M | 1 |
| Theroux, MC | 1 |
| Watt, S | 1 |
| Wong, CA | 1 |
| Xu, X | 1 |
| Huang, CJ | 1 |
| Chen, CL | 1 |
| Wang, CS | 1 |
| Cheng, KW | 1 |
| Chen, KH | 1 |
| Wang, CC | 1 |
| Concejero, AM | 1 |
| Cheng, YF | 1 |
| Huang, TL | 1 |
| Chiu, KW | 1 |
| Wang, SH | 1 |
| Lin, CC | 1 |
| Liu, YW | 1 |
| Jawan, B | 1 |
| Dainese, M | 1 |
| Quarta, M | 1 |
| Lyfenko, AD | 1 |
| Paolini, C | 1 |
| Canato, M | 1 |
| Reggiani, C | 1 |
| Dirksen, RT | 1 |
| Protasi, F | 1 |
| Ginz, HF | 1 |
| Levano, S | 1 |
| Girard, T | 1 |
| Urwyler, A | 1 |
| Hamel, C | 1 |
| Russell, T | 1 |
| Steel, AC | 1 |
| Hawryluck, LA | 1 |
| Lappa, A | 1 |
| Podestà, M | 1 |
| Capelli, O | 1 |
| Castagna, A | 1 |
| Di Placido, G | 1 |
| Alampi, D | 1 |
| Semeraro, F | 1 |
| Reingardiene, D | 1 |
| Green, G | 1 |
| Hollander, AS | 1 |
| Olney, RC | 1 |
| Blackett, PR | 1 |
| Marshall, BA | 1 |
| Edwards, JG | 1 |
| Newtont, JR | 1 |
| Ramzan, PH | 1 |
| Pilsworth, RC | 1 |
| Shepherd, MC | 1 |
| McKenzie, EC | 1 |
| Godden, SM | 1 |
| Finno, CJ | 1 |
| Murphy, MJ | 1 |
| Poels, PJ | 1 |
| Kluijtmans, LA | 1 |
| van Engelen, BG | 1 |
| Kilbane, BJ | 1 |
| Mehta, S | 1 |
| Backeljauw, PF | 1 |
| Shanley, TP | 1 |
| Crimmins, NA | 1 |
| Wagner, G | 1 |
| Rónai, L | 1 |
| López, JR | 2 |
| Linares, N | 1 |
| Cordovez, G | 1 |
| Terzic, A | 2 |
| Rojas, B | 1 |
| Gonzalez, MA | 1 |
| Watson, JD | 1 |
| Ferguson, C | 1 |
| Hinds, CJ | 1 |
| Skinner, R | 1 |
| Coakley, JH | 1 |
| Becker, BN | 1 |
| Ismail, N | 1 |
| Perez-Vela, JL | 1 |
| Sanchez Casado, M | 1 |
| Sanchez-Izquierdo Riera, JA | 1 |
| Ambros Checa, A | 1 |
| Caballero Cubedo, R | 1 |
| Alted Lopez, E | 1 |
| Dar, KJ | 1 |
| McBrien, ME | 1 |
| Pagala, M | 1 |
| Amaladevi, B | 1 |
| Bernstein, A | 1 |
| Herzlich, B | 1 |
| Namba, T | 1 |
| Grob, D | 1 |
| Montgomery, H | 1 |
| Myerson, S | 1 |
| Pollock, AN | 1 |
| McKenzie, AJ | 1 |
| Hodges, M | 1 |
| Snoeck, MM | 1 |
| Reeves, RK | 1 |
| Stolp-Smith, KA | 1 |
| Christopherson, MW | 1 |
| Kasamatsu, Y | 1 |
| Osada, M | 1 |
| Ashida, K | 1 |
| Azukari, K | 1 |
| Yoshioka, K | 1 |
| Ohsawa, A | 1 |
| Portel, L | 1 |
| Hilbert, G | 1 |
| Gruson, D | 1 |
| Favier, JC | 1 |
| Gbikpi-Benissan, G | 1 |
| Cardinaud, JP | 1 |
| Obata, R | 1 |
| Yasumi, Y | 1 |
| Suzuki, A | 1 |
| Nakajima, Y | 1 |
| Sato, S | 1 |
| Kozack, JK | 1 |
| MacIntyre, DL | 1 |
| Ramesh, V | 1 |
| Gardner-Medwin, D | 1 |
| Parr, MJ | 1 |
| Willatts, SM | 1 |
| Kaukonen, L | 1 |
| Hoffman, RS | 1 |
| Harioka, T | 1 |
| Sone, T | 1 |
| Toda, H | 1 |
| Miyake, C | 1 |
| Fox, AW | 1 |
| Levenson, JL | 1 |
| Materson, BJ | 1 |
| Preston, RA | 1 |
| Haverkort-Poels, PJ | 1 |
| Joosten, EM | 1 |
| Ruitenbeek, W | 1 |
6 reviews available for dantrolene and Rhabdomyolysis
| Article | Year |
|---|---|
[Neuroleptic malignant syndrome].
Topics: Acute Kidney Injury; Adult; Amantadine; Bromocriptine; Carbidopa; Contraindications; Dantrolene; Dia | 2002 |
Fatal malignant hyperthermia-like syndrome with rhabdomyolysis complicating the presentation of diabetes mellitus in adolescent males.
Topics: Adolescent; Dantrolene; Diabetes Mellitus, Type 2; Fatal Outcome; Humans; Hyperglycemic Hyperosmolar | 2003 |
Exertional heat stroke induced by amphetamine analogues. Does dantrolene have a place?
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Blood Coagulation Disorders; Dancing; Dantrolene; | 1993 |
MDMA induced hyperthermia: report of a fatality and review of current therapy.
Topics: Acute Kidney Injury; Adolescent; Blood Coagulation Disorders; Dantrolene; Fatal Outcome; Fever; Hall | 1996 |
Malignant hyperthermia.
Topics: Adult; Anesthesia; Child; Dantrolene; Exercise; Health Education; Heat Stroke; Humans; Malignant Hyp | 2001 |
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Child; Dantrol | 1985 |
2 trials available for dantrolene and Rhabdomyolysis
| Article | Year |
|---|---|
The efficacy of dantrolene sodium in controlling exertional rhabdomyolysis in the Thoroughbred racehorse.
Topics: Administration, Oral; Animals; Creatine Kinase; Cross-Over Studies; Dantrolene; Double-Blind Method; | 2003 |
Myoplasmic Ca2+ concentration during exertional rhabdomyolysis.
Topics: Adult; Biopsy; Calcium; Dantrolene; Female; Humans; Intracellular Fluid; Male; Muscle, Skeletal; Phy | 1995 |
40 other studies available for dantrolene and Rhabdomyolysis
| Article | Year |
|---|---|
Oral Dantrolene for Myopathic Symptoms in Malignant Hyperthermia-Susceptible Patients: A 25-Year Retrospective Cohort Study of Adverse Effects and Tolerability.
Topics: Dantrolene; Drug-Related Side Effects and Adverse Reactions; Fatigue; Halothane; Humans; Malignant H | 2023 |
Oral Dantrolene Reduces Myalgia and Hyperckemia in a Child with RYR1-Related Exertional Myalgia/Rhabdomyolysis.
Topics: Child; Child, Preschool; Dantrolene; Humans; Muscles; Myalgia; Rhabdomyolysis; Ryanodine Receptor Ca | 2023 |
Recurrent Dystonic Crisis and Rhabdomyolysis Treated with Dantrolene in Two Patients with Aromatic L-Amino Acid Decarboxylase Deficiency.
Topics: Amino Acid Metabolism, Inborn Errors; Aromatic-L-Amino-Acid Decarboxylases; Child; Child, Preschool; | 2020 |
Neuroleptic malignant syndrome in a COVID-19 patient.
Topics: Acute Kidney Injury; Antipsychotic Agents; Betacoronavirus; Bromocriptine; C-Reactive Protein; Coron | 2020 |
[Rhabdomyolysis during Perioperative Period after Cardiac Surgery].
Topics: Cardiac Surgical Procedures; Dantrolene; Humans; Male; Malignant Hyperthermia; Middle Aged; Perioper | 2020 |
Beneficial effects of dantrolene in the treatment of rhabdomyolysis as a potential late complication associated with COVID-19: a case report.
Topics: Adult; COVID-19; Dantrolene; Humans; Male; Malignant Hyperthermia; Muscle Relaxants, Central; Rhabdo | 2021 |
Pathways of calcium regulation, electron transport, and mitochondrial protein translation are molecular signatures of susceptibility to recurrent exertional rhabdomyolysis in Thoroughbred racehorses.
Topics: Animals; Calcium; Dantrolene; Disease Susceptibility; Electron Transport; Female; Genetic Predisposi | 2021 |
[Prolonged neuroleptic malignant syndrome after Haloperidol injection].
Topics: Antipsychotic Agents; Dantrolene; Haloperidol; Humans; Male; Middle Aged; Neuroleptic Malignant Synd | 2018 |
[Abortive course of malignant hyperthermia following preclinical induction of general anesthesia using succinylcholine].
Topics: Anesthesia, General; Anesthetics, Intravenous; Dantrolene; Female; Fentanyl; Humans; Malignant Hyper | 2018 |
Management of a Patient With a History of Nonanesthesia-Related Malignant Hyperthermia Undergoing Laparoscopic Cholecystectomy: A Case Report.
Topics: Adult; Cholecystectomy, Laparoscopic; Dantrolene; Humans; Male; Malignant Hyperthermia; Muscle Relax | 2018 |
TREATMENT OF SUSPECTED EXERTIONAL MYOPATHY USING DANTROLENE IN A COYOTE ( CANIS LATRANS).
Topics: Animals; Animals, Zoo; Coyotes; Dantrolene; Female; Muscle Relaxants, Central; Muscular Diseases; Ph | 2018 |
Consensus Statement of the Malignant Hyperthermia Association of the United States on Unresolved Clinical Questions Concerning the Management of Patients With Malignant Hyperthermia.
Topics: Consensus; Dantrolene; Drug Administration Schedule; Evidence-Based Medicine; Exercise; Humans; Mali | 2019 |
Magnesium sulfate - An effective agent could delay the progression of fulminant malignant hyperthermia.
Topics: Anesthesia, General; Anesthetics; Calcium; Catecholamines; Dantrolene; Disease Progression; Fever; H | 2019 |
Rhabdomyolysis after liver transplantation: a case report.
Topics: Arrhythmias, Cardiac; Biliary Atresia; Child, Preschool; Dantrolene; Female; Humans; Liver Transplan | 2008 |
Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice.
Topics: Anesthetics; Animals; Caffeine; Calcium; Calcium-Binding Proteins; Calsequestrin; Central Nervous Sy | 2009 |
Dantrolene for severe rhabdomyolysis in Staphylococcus aureus toxic shock syndrome.
Topics: Dantrolene; Humans; Male; Middle Aged; Rhabdomyolysis; Shock, Septic; Staphylococcal Infections | 2012 |
Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene.
Topics: Anesthetics, Inhalation; Antipsychotic Agents; Body Temperature; Caffeine; Central Nervous System St | 2012 |
Successful treatment of a complicated case of neuroleptic malignant syndrome.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Dantrolene; Disseminated Intravascular Coagulatio | 2002 |
A fatal case of malignant hyperthermia complicated by generalized compartment syndrome and rhabdomyolysis.
Topics: Adult; Anesthetics, Intravenous; Compartment Syndromes; Dantrolene; Fatal Outcome; Hemorrhage; Human | 2003 |
Effect of oral administration of dantrolene sodium on serum creatine kinase activity after exercise in horses with recurrent exertional rhabdomyolysis.
Topics: Administration, Oral; Animals; Creatine Kinase; Cross-Over Studies; Dantrolene; Food Deprivation; Ho | 2004 |
The effect of dantrolene sodium in Very Long Chain Acyl-CoA Dehydrogenase Deficiency.
Topics: Acyl-CoA Dehydrogenase, Long-Chain; Aged; Dantrolene; Female; Humans; Muscle Relaxants, Central; Rha | 2005 |
Approach to management of malignant hyperthermia-like syndrome in pediatric diabetes mellitus.
Topics: Adolescent; Black or African American; Butyryl-CoA Dehydrogenase; Child; Dantrolene; Diabetes Mellit | 2006 |
[Acute renal failure in neuroleptic malignant syndrome].
Topics: Acute Kidney Injury; Adult; Antipsychotic Agents; Bromocriptine; Dantrolene; Humans; Male; Muscle Re | 1995 |
Elevated myoplasmic calcium in exercise-induced equine rhabdomyolysis.
Topics: Animals; Calcium; Dantrolene; Horse Diseases; Horses; Microelectrodes; Muscle, Skeletal; Physical Ex | 1995 |
The neuroleptic malignant syndrome and acute renal failure.
Topics: Acute Kidney Injury; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Fever; Humans; Midd | 1994 |
Neuroleptic malignant syndrome in a patient with head injury.
Topics: Adolescent; Bromocriptine; Craniocerebral Trauma; Creatine Kinase; Dantrolene; Hemofiltration; Human | 1996 |
Dantrolene sodium reduces the enhanced leakage of creatine kinase caused by ethanol, cocaine, and electrical stimulation in isolated fast and slow muscles of rat.
Topics: Animals; Cell Membrane Permeability; Cocaine; Creatine Kinase; Culture Techniques; Dantrolene; Elect | 1997 |
3,4-methylenedioxymethamphetamine (MDMA, or "ecstasy") and associated hypoglycemia.
Topics: Acute Disease; Adult; Dantrolene; Female; Fever; Hallucinogens; Humans; Hypoglycemia; Muscle Relaxan | 1997 |
Propofol and malignant hyperthermia susceptibility.
Topics: Acidosis; Adolescent; Adult; Aged; Anesthetics, Intravenous; Arrhythmias, Cardiac; Cause of Death; C | 1997 |
Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure.
Topics: Adult; Baclofen; Catheters, Indwelling; Dantrolene; Disseminated Intravascular Coagulation; Equipmen | 1998 |
Rhabdomyolysis after infection and taking a cold medicine in a patient who was susceptible to malignant hyperthermia.
Topics: Adult; Caffeine; Chlorpheniramine; Common Cold; Dantrolene; Halothane; Humans; In Vitro Techniques; | 1998 |
Malignant hyperthermia and neuroleptic malignant syndrome in a patient during treatment for acute asthma.
Topics: Acute Disease; Adjuvants, Anesthesia; Adult; Anesthetics, Inhalation; Asthma; Bronchodilator Agents; | 1999 |
Rhabdomyolysis in association with Duchenne's muscular dystrophy.
Topics: Acute Disease; Anesthetics, Inhalation; Child; Dantrolene; Humans; Male; Methyl Ethers; Muscle Relax | 1999 |
Familial paroxysmal rhabdomyolysis: management of two cases of the non-exertional type.
Topics: Biopsy; Child, Preschool; Combined Modality Therapy; Creatine Kinase; Dantrolene; Fasting; Female; H | 1992 |
Fatal theophylline poisoning with rhabdomyolysis. A potential role for dantrolene treatment.
Topics: Acute Kidney Injury; Adult; Compartment Syndromes; Dantrolene; Drug Overdose; Humans; Male; Rhabdomy | 1991 |
Cocaine.
Topics: Acidosis; Ammonium Chloride; Bicarbonates; Cocaine; Dantrolene; Humans; Malignant Hyperthermia; Rhab | 1990 |
Malignant hyperthermia in a hemodialysis patient.
Topics: Acidosis; Dantrolene; Female; Humans; Hyperkalemia; Intraoperative Complications; Malignant Hyperthe | 1989 |
More on rhabdomyolysis associated with cocaine intoxication.
Topics: Cocaine; Dantrolene; Humans; Rhabdomyolysis | 1989 |
Myoglobinuria versus hemoglobinuria.
Topics: Acute Kidney Injury; Alcoholism; Biopsy; Creatine Kinase; Dantrolene; Diagnosis, Differential; Hemog | 1988 |
Prevention of recurrent exertional rhabdomyolysis by dantrolene sodium.
Topics: Dantrolene; Female; Humans; Middle Aged; Mitochondria, Muscle; Oxidative Phosphorylation; Physical E | 1987 |